• About Fertility
    • reproductive system basics
    • female infertility
    • male infertility
    • lifestyle & infertility
    • first steps
    • seeking help
  • Testing & Diagnosis
    • initial steps
    • fertility tests for women
    • female symptoms
    • female diagnosis
    • fertility tests for men
    • male symptoms
    • male diagnosis
    • the right healthcare provider
    • unexplained infertility
  • Therapy Options
    • starting fertility treatment
    • drug therapies
    • surgery for infertility
    • assisted reproduction
  • After Therapy
    • pregnancy after fertility therapy
    • childfree living
  • Coping
    • friends & family
    • recommended resources
    • self-help
    • secondary infertility
    • pregnancy loss
  • Financial Aspects
    • fertility treatment coverage
  • Home
  • Print
  • Glossary
  • Send Page

Selected References

The information in this website was sourced from many scientific publications. Here is a selection of this literature, including current Canadian references.

  1. Assisted reproductive technologies (ART) in Canada: 2003 results from the Canadian ART Registry. Joanne Gunby, M.Sc.,a and Salim Daya, M.B.,b on behalf of the IVF Directors Group of the Canadian Fertility and Andrology Society. Fertility and Sterility 2007, Article in press.
  2. Assisted Human Reproduction Act ( 2004, c. 2) Act current to August 31st, 2007. Health Canada. Available at: http://laws.justice.gc.ca/en.Accessed September 21, 2007.
  3. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Jacky Boivin, Laura Bunting, John A.Collins and Karl G.Nygren. Hum Reprod 2007 Jun;22(6):1506-1512.
  4. Incidence and complications of multiple gestation in Canada: proceedings of an expert meeting. Canadian Fertility and Andrology Society. RBM Online 2007; 14(6):773-790. Available at: www.rbmonline.com. Accessed September 21, 2007.
  5. Human Assisted Reproduction Live Birth Rates for Canada. Canadian Fertility and Andrology Society. Press Release, November 23, 2006. Available at: http://www.cfas.cfwebtools.com. Accessed September 21, 2007.
  6. Sexually Transmitted Infections Data Tables, 2006. Surveillance and Epidemiology Section, Community Acquired Infections Division, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, 2006. Available at: http://www.phac-aspc.gc.ca/std-mts/stddata_pre06_04/index_tab_e.htm. Accessed September 21, 2007.
  7. Guidelines for the number of embryos to transfer following in vitro fertilization. Joint SOGC – CFAS Guideline. Society of Obstetricians and Gynecologists of Canada and the Canadian Society of Fertility and Andrology. JOGC September 2006; No. 182:799-813.
  8. Pregnancy outcomes after assisted reproductive technology. Joint SOGC – CFAS Guideline. Society of Obstetricians and Gynecologists of Canada and the Canadian Society of Fertility and Andrology. JOGC March 2006; No. 173:220-233.
  9. Surrogate pregnancy: a guide for Canadian prenatal health care providers. Reilly DR. CMAJ 2007; 176(4):483-485.
  10. Perimenopausal and postmenopausal health. Cheung AM, Chaudhry R, Kapral M, Jackevicius C, Robinson G. BMC Women's Health 2004, 4(Suppl 1):S23. Available at: http://www.biomedcentral.com. Accessed September 21, 2007.
  11. Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics. Hughes EG, Giacomini M. Fertil Steril 2001; 76:431-442.
  12. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Hum Reprod Update. 2006; 12(6):651-671.
  13. Clinical gynecologic endocrinology and infertility. Speroff L, Glass RH, Kase NG. Baltimore: Williams and Wilkins, 1999.
  14. Definition and prevalence of subfertility and infertility. Gnoth C, Godehardt E, Frank-Herrmann P, Friol K, Tigges J, and Freundl G. Human Reproduction 2005; 20(5):1144-1147.
  15. Female subfertility. J. Evers. The Lancet, 2002; 360 (9327):151-159.
  16. Fertility and ageing. Baird DT et al for the ESHRE Capri workshop Group. Hum Reprod Update 2005; 11: 261-276.
  17. Diverging fertility among U.S. women who delay childbearing past age 30. Martin SP. Demography 2000; 37:523-533.
  18. Fertility treatment options in women over 40 years old. Hull MGR. In: Lobo RA, ed. Perimenopause. Springer, New York, 1997:287­307.
  19. Reversing the natural decline human fertility: an extended clinical trial of oocyte donation to women of advanced reproductive age. Sauer MV, Paulson RJ, Lobo RA.
    JAMA 1992; 268:1275-1279.
  20. Effects of male age on semen quality and fertility: a review of the literature. Kidd SA, Eskenazi B, Wyrobek AJ. Fertil Steril 2001; 75(2):237-248.
  21. Reproductive functions of the ageing male. Kuhnert B, Nieschlag E. Hum Reprod Update 2004; 10(4):327-339.
  22. Negative lifestyle is associated with a significant reduction in fecundity. Hassan MA, Killick SR. Fertil Steril 2004; 81:384-392.
  23. Male factor subfertility: possible causes and the impact of nutritional factors. Wong WY, Thomas CMG, Merkus JMWM, Zielhuis GA, Steegers-Theunissen RPM. Fertil Steril 2002; 73(3):435-442.
  24. Alcohol's effects on male reproduction. Emanuele MA, Emanuele NV. Alcohol Health Res World 1998; 22(3):195-201.
  25. The effects of moderate alcohol consumption on female hormone levels and reproductive function. Gill J. Alcohol Alcohol. 2000; 35:417-423.
  26. Smoking and infertility. The Practice Committee of the American Society for Reproductive Medicine. Fertil Steril 2004; 8:1181-1186.
  27. Parental smoking and children’s respiratory health: independent effects of prenatal and postnatal exposure. Pattenden S et al. Tobacco Control 2006;15:294-301.
  28. Effects of subfertility cause, smoking and body weight on the success rate of IVF. Lintsen AM, Pasker-de Jong PC, de Boer EJ, Burger CW, Jansen CA, Braat DD, van Leeuwen FE. Hum Reprod. 2005; 20(7):1867-1875.
  29. Drug abuse and reproduction. Smith CG, Asch RH. Fertil Steril 1987; 48:355-373.
  30. Weight-related changes in reproduction function. Review. Reid RL, Van Vugt DA.
    Fertil Steril. 1987; 48(6):905-913.
  31. Improving reproductive performance in overweight/obese women with effective weight management. Norman RJ, Noakes M, Wu R, Davies MJ, Moran L, Wang JX. Hum Reprod Update 2004; 10:267-280.
  32. Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Jensen TK, Andersson AM, Jorgensen N, Andersen AG, Carlsen E, Petersen JH, Skakkebaek NE. Fertil Steril 2004; 82(4):863-870.
  33. Improved seminal characteristics in infertile men after a conservative treatment based on the avoidance of testicular hyper thermia. Lynch R, Lewis-Jones DI, Machin DG, Desmond AD. Fertil Steril 1986; 46:476-479.
  34. Surgery or embolisation for varicocele in subfertile men. Evers JL, Collins JA. Cochrane Database Syst Rev 2004; (3): CD000479
  35. A systematic review of tests predicting ovarian reserve and IVF outcome. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. Hum Reprod Update. 2006;12(6):685-718.
  36. Optimal use of infertility diagnostic tests and treatments. Crosignani PG, Ruben BL for The ESHRE Capri Workshop Group. Hum Reprod. 2000; 15(3):723-732.
  37. Investigation of the infertile couple: a basic fertility work-up performed within 12 months of trying to conceive generates costs and complications for no particular benefit. van der Steeg JW, Steures P, Hompes PG, Eijkemans MJ, van der Veen F, Mol BW. Hum Reprod 2005; 20(10):2672-2674.
  38. Laparoscopic 'drilling' by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. C Farquhar, RJ Lilford, J Marjoribanks, P Vandekerckhove. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD001122.
  39. Effect of overweight and obesity on assisted reproductive technology a systematic review. Maheshwari A, Stofberg L, Bhattacharya S Hum Reprod Update. 2007; 13(5):433-444.
  40. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Mathur R, Kailasam C, Jenkins J. Hum Fertil (Camb) 2007; 10(2):75-85.
  41. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. Reprod Biomed Online. 2006; 13(5):628-638.
  42. An international survey of the health economics of IVF and ICSI. Collins J. Hum Reprod Update 2002; 8:265-277.
  43. The prognostic power of the post­coital test for natural conception depends on duration of infertility. Glazener CM, Ford WC, Hull MG. Hum Reprod 2000; 15:1953­1957.
  44. Three million babies born using assisted reproductive technologies. International Committee for Monitoring Assisted Reproductive Technologies (ICMART). Press Release, June 26, 2006. Presented at the 22nd annual conference of the European Society of Human Reproduction and Embryology, 2006. Available at: http://www.eshre.com. Accessed September 21, 2007.
  45. In vitro fertilization. Van Voorhis BJ. N Engl J Med 2007; 356:379-386.
  46. Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomised controlled trial.
    Bayram N, van Wely M, Kaaijk EM, Bossuyt PM, van der Veen F. BMJ. 2004;328:192.
  47. Naturally-occurring antisperm antibodies in men: interference with fertility and clinical implications. An update. Francavilla F, Santucci R, Barbonetti A, Francavilla S. Front Biosci. 2007; 12:2890-2911.
  48. Antisperm antibodies: origin, regulation, and sperm reactivity in human infertility. Naz RK, Menge AC. Fertil Ster 1994; 61:1001-1013.
  49. Intracytoplasmic sperm injection: an assisted reproductive technique and its outcome to overcome infertility. Sarkar NN. J Obstet Gynaecol 2007; 27:347-353.
  50. Medical and surgical management of male infertility. Schiff JD, Ramírez ML, Bar-Chama N. Endocrinol Metab Clin North Am 2007; 36(2):313-331.
  51. Diagnostic approach to the infertile male patient. Jarow JP. Endocrinol Metab Clin North Am 2007; 36(2):297-311.
  52. Ovulation induction: a mini review. Messinis IE. Hum Reprod 2005; 20(10):2688-2697.
  53. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Kettel LM, Scholl G, Bonaventura L, Pang S, Sacks P, Chantilis S, Mahony M; Follistim Pen OI Study Group. Reprod Biomed Online. 2004; 9(4):373-380.
  54. Complications of IVF and ovulation induction 2005. Klemetti R, Sevon T, Gissler M, Hemminki E. Hum Reprod. 2005; 20(12):3293-3300.
  55. Factors that affect infertility patients' decisions about disposition of frozen embryos. Lyerly AD, Steinhauser K, Namey E, Tulsky JA, Cook-Deegan R, Sugarman J, Walmer D, Faden R, Wallach E. Fertil Steril 2006; 85(6):1623-1630.
  56. Reasons for drop-out in an in vitro fertilization/intracytoplasmatic sperm injection program. Smeenk JM, Verhaak CM,Stolwijk AM, Kremer JA, Braat DD.
    Fertil Steril 2004; 81:262-268.
  57. Stress and marital satisfaction among women before and after their first cycle of in vitro fertilization and intracytoplasmatic sperm injection.Verhaak CM, Smeenk JM, Eugster A, van Minnen A, Kremer JA, Kraaimaat FW. Fertil Steril 2001; 76:525-531.
  • Home
  • Contact Us
  • Privacy Policy
  • References
  • Site Map
© 2008 Schering–Plough Corporation. All rights reserved.